Srinivas Akkaraju Net Worth & Insider Trades

Srinivas Akkaraju - Director, Syros Pharmaceuticals, Inc

As of September 19, 2022

What is Srinivas Akkaraju's Net Worth?

The current estimated net worth of Syros Pharmaceuticals, Inc's Director, Srinivas Akkaraju, is estimated to be about $206.73M . Srinivas Akkaraju owns about 1,274,616 units of Syros Pharmaceuticals, Inc common stock. In the last 5 years at Syros Pharmaceuticals, Inc, Srinivas Akkaraju has sold an estimated value of $3.86M worth.

What is Srinivas Akkaraju's Past Insider Trading?

Srinivas Akkaraju's largest purchase order was 533,332 units , worth over $4M on April 11, 2019. Srinivas Akkaraju's largest sale order was 159,327 units , worth over $2.09M on August 19, 2020. In total, Srinivas Akkaraju has made about 14 transactions over 5 years of their time at Syros Pharmaceuticals, Inc. Srinivas Akkaraju usually trades in June, with the busiest year in 2020.

SRINIVAS AKKARAJU

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What is Srinivas Akkaraju's' Mailing Address?

  • Mailing address is 565 Everett Avenue Palo Alto CA 94301 CA

What are Syros Pharmaceuticals, Inc's Past Insider Trades?

Syros Pharmaceuticals, Inc's most recent insider trade came on October 3, 2022 by Timothy Tyson who bought 16,932 units worth $105.96K . In the last 6 years, insiders at Syros Pharmaceuticals, Inc have sold an estimated value of $8.66M and bought an estimated value of $48.37M worth of shares. Insider trading is most common in June, with the busiest year in 2022. The most active traders at the company are Richard Young, Director,  Eric Olson, Chief Scientific Officer,  and Srinivas Akkaraju, Director .

Syros Pharmaceuticals, Inc. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1